 |
|
|
Health
2000 1999
1998 1997 1996
1995
Documents from
2001 to 2003 (click)
2000
A
Briefing on TRIPS, 2000.
Author: World Health Organization, Regional Office for the
Western Pacific, Manila.
Access
to essential medicines in developing countries: does the WTO TRIPS
Agreement hinder it?, 2000
Author: J. Watal / Science, Technology and Development
Discussion Paper, No. 8.
A
patent policy proposal for global diseases, 2000.
Author: J. Olson Lanjouw.
Drug
patents in French-speaking Africa, 2000.
Author: P. Boulet, Gilles-Bernard Forte / Unofficial translation
of the MSF-WHO-UNAIDS report, Joint Mission MSF-OMS-ONUSIDA, Cameroun,
6-10 February 2000.
Drug
pricing [in South Africa], 2000.
Authors: A. Gray, T. Matsebula / South African Healt Review
2000, Briefing Summary, Health Systems Trust.
El
ABC del Patentamiento de la Vida, 2000.
Author: Genetic Resources Action International (GRAIN).
El
Sistema de Patentes en Crisis? Practicas de Patentamiento Farmaceutico,
2000.
Author: Carlos Correa.
Essential Drugs in Southern
Africa Need Protection from Public Health Safeguards under TRIPS,
2000.
Author: R. Loewenson / BRIDGES, ICTSD, Vol. 4, N°7,
September 2000.
Global
trade and health: key linkages and future challenges, 2000.
Authors: Douglas W. Bettcher, Derek Yach, G. Emmanuel Guindon
/ Bulletin of the World Health Organization, Vol. 78, N°4.
How
Stronger Patent Protection in India might affect the Behavior of
Transnational Pharmaceutical Industries, 2000.
Author: Carsten Fink / Policy Research Working Paper,
The World Bank Development Research Group, N°2352.
Integrating
Public Health Concerns into Patent Legislation in Developing Countries,
2000.
Author: C. Correa / South Centre.
Patent
Law and Its Application to the Pharmaceutical Industry: An Examination
of the Drug Price Competition and Patent Term Extension Act of 1984.,
2000.
Authors: W. Schacht, J. Thomas / Congressional Research
Service Documents, Washington, D.C., USA.
Patent
Protection and Access to HIV/AIDS Pharmaceuticals in Sub-Saharan
Africa., 2000.
Authors: Lee Gillespie-White, Venus Griffith, Albena Petrova,
Stetson Sanders, Paul Salmon / International Intellectual Property
Institute (IIPI).
Patent
situation of HIV/AIDS-related drugs in 80 countries, 2000.
Authors: P. Boulet, J. Perriens, F. Renaud-Théry /
Joint UNAIDS/WHO publication.
Pharmaceuticals
and the WTO TRIPS Agreement: Questions and Answers, 2000.
Authors: P. Boulet, J. Perriens, F. Renaud-Théry,
G. Velasquez / Joint UNAIDS/WHO publication.
Report
of the Inter-Regional Workshop on Intellectual Property Rights in
the Context of Traditional Medicine, 2000.
Author: World Health Organisation (WHO) / Bangkok, Thailand,
6–8 December 2000.
The
Pharmaceutical Industry and World Intellectual Property Standards,
2000.
Author: F. M. Scherer / Vanderbilt Law Review, Vol.
53, N°6.
The Canadian
Generic Medicines Panel A Dangerous Precedent in Dangerous Times,
2000.
Author: R. Howse / BRIDGES, ICTSD, Vol. 4, N°3,
April 2000.
The
Long Shadow of Patent Expiration: Do RX to OTC Switches Provide
an Afterlife?, 2000.
Authors: Ernst R. Berndt, Davina Ling and Margaret K. Kyle
/ paper presented at the National Bureau of Economic Research -
Conference on Research in Income and Wealth, Symposium on Scanner
Data and Price Indexes, Arlington, Virginia, September 15-16, 2000.
The
TRIPS Agreement and pharmaceuticals: report of the ASEAN workshop
on the TRIPS agreement and its impact on pharmaceuticals, 2000.
Authors: K. Timmermans, T. Hutadjulu / Directore General
of Drug and Food Control (Indonesia) and World Health Organization
(WHO).
World
Trade Organisation agreements: implications for equity and health
in Southern Africa, 2000.
Author: G. Munot / Equinet Policy Series, Regional
Network for Equity in Health in Southern Africa
(EQUINET) and Southern African Development Community (SADC) Health
Sector Co-ordinating Unit, N°4.
1999
Essential
drugs in the new international economic environment, 1999.
Authors: G. Velasquez, P. Boulet / Bulletin of the World
Health Organization, Vol. 77, N°3.
Globalization
and Access to Drugs. Perspectives on the WTO/TRIPS Agreement,
1999.
Authors: G. Velasquez, P. Boulet / WHO Health Economics and
Drugs, DAP Series, N°7.
Intellectual
Property Rights and the Pharmaceutical Industry The Consequence
of Incomplete Protection, 1999.
Author: William McArthur / in Competitive Strategies for
the Protection of Intellectual Property, edited by Owen Lippert,
The Fraser Institute, Vancouver, Canada, pp. 85-104.
L'OMS
se penche sur les rapports entre commerce et produits pharmaceutiques,
1999.
Author: Valery Abramov / Organisation Mondiale de la Santé
(OMS).
TRIPS
and Pharmaceuticals, 1999.
Author: Eva Ombaka / Echoes, the World Council of
Churches' cluster on "Issues and Themes", Justice, Peace and Creation
team.
1998
Can
patents deter innovation? The anticommons in biomedical research,
1998.
Authors: M.A. Heller, R.S Eisenberg / Science, N°280,
pp. 698-701.
Pharmaceuticals:
the role of biotechnology and patents, 1998.
Author: J. Dumoulin, J./ Biotechnology and Development
Monitor, N°35, p.13-15
The
Introduction of Pharmaceutical Product Patents in India: Heartless
Exploitation of the Poor and Suffering, 1998.
Author: J. Olson Lanjouw / National Bureau of Economic Research
Working Paper, N°6366
1997
Health
Economics: The Uruguay Round and Drugs, 1997.
Author: Carlos M. Correa / WHO.
1996
Product
Patent Reform and its Impact on Korea's Pharmaceutical Industry,
1996.
Authors: Sumner J. La Croix, Akihiko Kawaura / International
Economic Journal, Vol. 10, N°1, Spring 1996.
1995
Alternative
Drug Pricing Policies in the Americas, 1995.
Author: A.Z. Sarmiento / Health Economics and Drugs, DAP Series,
WHO, N°1. |
|
|
|
|
